当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析 - 现金流量表

圣湘生物

(688289)

  

流通市值:99.37亿  总市值:99.37亿
流通股本:5.79亿   总股本:5.79亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金417,204,958.571,750,017,306.761,165,438,726.07754,411,397.4
  收到的税费返还541,198.2118,446,837.819,573,204.932,075,796.95
  收到其他与经营活动有关的现金15,031,906.56133,711,848.6591,249,045.729,242,015.38
  经营活动现金流入小计432,778,063.341,902,175,993.211,276,260,976.7785,729,209.73
  购买商品、接受劳务支付的现金124,344,007.69416,825,477.31410,703,664.37274,310,770.04
  支付给职工以及为职工支付的现金148,205,336.6545,985,597.64413,979,198.36292,071,383.83
  支付的各项税费25,261,000.42108,801,844.6398,159,562.277,772,148.13
  支付其他与经营活动有关的现金135,932,106.78646,602,229.93437,898,603.44284,421,748.75
  经营活动现金流出小计433,742,451.491,718,215,149.511,360,741,028.37928,576,050.75
  经营活动产生的现金流量净额-964,388.15183,960,843.7-84,480,051.67-142,846,841.02
二、投资活动产生的现金流量:
  收回投资收到的现金24,650,759.23841,044,150827,033,179.49550,459,322.4
  取得投资收益收到的现金298,822.986,457,386.125,925,206.634,570,623.1
  处置固定资产、无形资产和其他长期资产收回的现金净额333,032.952,444,806.471,744,428.23430,695.32
  收到的其他与投资活动有关的现金--161,748,184.76160,406,184.76
  投资活动现金流入小计25,282,615.16849,946,342.59996,450,999.11715,866,825.58
  购建固定资产、无形资产和其他长期资产支付的现金59,150,764.9369,767,235.79172,108,929.87109,025,361.83
  投资支付的现金213,000,0001,050,900,000.011,820,333,333.341,506,333,333.34
  取得子公司及其他营业单位支付的现金-715,472,815.24--
  投资活动现金流出小计272,150,764.92,136,140,051.041,992,442,263.211,615,358,695.17
  投资活动产生的现金流量净额-246,868,149.74-1,286,193,708.45-995,991,264.1-899,491,869.59
三、筹资活动产生的现金流量:
  吸收投资收到的现金-11,782,633.12--
  取得借款收到的现金77,128,870.151,106,611,084.191,102,782,275942,782,275
  收到其他与筹资活动有关的现金--6,302,199.136,302,199.13
  筹资活动现金流入小计77,128,870.151,118,393,717.311,109,084,474.13949,084,474.13
  偿还债务支付的现金28,400,000403,130,000418,530,000394,130,000
  分配股利、利润或偿付利息支付的现金7,562,599.07333,680,980.05323,222,505.64169,338,392.05
  支付其他与筹资活动有关的现金75,322.647,205,321.8917,294,522.6816,687,372.4
  筹资活动现金流出小计36,037,921.71744,016,301.94759,047,028.32580,155,764.45
  筹资活动产生的现金流量净额41,090,948.44374,377,415.37350,037,445.81368,928,709.68
四、汇率变动对现金及现金等价物的影响-3,987,574.39-2,230,122.3-389,317.971,279,806.12
五、现金及现金等价物净增加额-210,729,163.84-730,085,571.68-730,823,187.93-672,130,194.81
  加:期初现金及现金等价物余额3,746,542,445.244,476,628,016.924,476,628,016.924,476,628,016.92
  期末现金及现金等价物余额3,535,813,281.43,746,542,445.243,745,804,828.993,804,497,822.11
补充资料:
  净利润-153,924,782.58-142,740,148.15
  资产减值准备-29,650,010-8,604,506.41
  固定资产和投资性房地产折旧-154,481,319.39-73,201,522.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-154,481,319.39-73,201,522.15
  无形资产摊销-49,298,222.76-19,430,871.45
  长期待摊费用摊销-19,436,185.68-12,494,242.34
  处置固定资产、无形资产和其他长期资产的损失-2,946,565.51-3,044,178.72
  固定资产报废损失-2,413,387.46-91,940
  公允价值变动损失--48,574,301.3--47,493,750.56
  财务费用-24,125,374.74--34,065,418.92
  投资损失-55,237,813-24,953,300.33
  递延所得税--9,324,476.39-32,473,204.4
  其中:递延所得税资产减少--12,363,823.8-562,014.25
    递延所得税负债增加-3,039,347.41-31,911,190.15
  存货的减少--10,311,104.98-6,934,895.17
  经营性应收项目的减少--39,973,098.07--176,965,839.41
  经营性应付项目的增加--110,126,284.26--165,602,089.86
  其他--129,039,885.16--32,768,898.14
  现金的期末余额-3,746,542,445.24-3,804,497,822.11
  减:现金的期初余额-4,476,628,016.92-4,476,628,016.92
  现金及现金等价物的净增加额--730,085,571.68--672,130,194.81
公告日期2026-04-302026-04-302025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑